06 February 2024, Baden-Württemberg, Mannheim: Claudia Fleischer, Managing Director of Roche Diagnostics GmbH, stands on a staircase at Roche Pharma's annual press conference. The business results for ...

In recent developments, Roche has featured prominently in the race to develop TIGIT inhibitors for cancer immunotherapy, while Ibex Medical Analytics expanded its AI pathology platform to support ...

Wednesday, January 7, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Micron ...

The stock price of Roche (OTCMKTS: RHHBY) is up 10% in a week, compared to around a 10% fall for its peer Eli Lilly stock (NYSE: LLY) over this period. The rise in Roche stock in recent days can ...

Tuesday, Roche Holding AG (OTC:RHHVF) (ROG:SW) (OTC: RHHBY (OTC:RHHBY)), a pharmaceutical giant with a market capitalization of $265.76 billion, saw its price target increased by Deutsche Bank ...

Roche Holding AG's Q2 and 1H 2025 earnings will, initially, broadly please the market despite recent pipeline and commercial setbacks. The pharmaceuticals division delivered strong revenue growth, up ...

Roche reported positive Phase III results on trials of its new multiple sclerosis (MS) drug today. Fenebrutinib appears effective at treating both relapsing multiple sclerosis and primary progressive ...

In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to ...

This morning, Roche announced results of its new GLP-1 drug trial showing patients losing an average of 7.3% of their body weight after four weeks of treatment, which it calls a "clinically meaningful ...

Roche Holding AG stock has seen a 13% price rise in the past month following positive trial results for its obesity treatment. Weight management and associated diseases like diabetes have huge ...

The stock price of Roche (OTCMKTS: RHHBY) trades at $35 per share, about 33% below its peak level of over $53 seen in April 2022. In contrast, its peer Bristol Myers Squibb stock (NYSE: BMY) saw a 48% ...

06 February 2024, Baden-Württemberg, Mannheim: Daniela Kahlert, Managing Director of Roche Diagnostics Deutschland GmbH, stands on a staircase at Roche Pharma's annual press conference. The business ...